Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 4850 of 5804
-
Brain zaps reveal Stroke's impact on movement
Knowledge-focused CompletedThe purpose of this study is to investigate the effects of transcranial magnetic stimulation (TMS) on motor cortex excitability in individuals who have suffered stroke and to study the influence of the phase of the oscillatory rhythm (mu frequency) on motor excitability in stroke…
Phase: NA • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Getting brain injury patients moving earlier in the ICU: a safety check
Knowledge-focused CompletedIntroduction Patients with severe brain injury are often restricted to bed rest during the early period of brain injury which may lead to unwanted secondary complications. There is lack of evidence of when to initiate the first mobilisation. The Sara Combilizer® is an easy and ef…
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:52 UTC
-
Easing the squeeze: new study aims to reduce ear pain in oxygen chambers
Symptom relief CompletedEustachian tube dysfunction (ETD) and middle ear barotrauma (MEB) are common reported complications during hyperbaric oxygen treatment. The Phase I study data was the first to demonstrate a statistically significant decrease in the occurrence of symptomatic ETD and middle ear bar…
Phase: NA • Sponsor: Northwell Health • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New cancer drug NB004 tested in Early-Stage trial
Disease control TerminatedThis is a Phase 1, Open-label, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of NB004 Administered as Monotherapy or Combination Therapy in Subjects with Advanced Solid Tumors
Phase: PHASE1 • Sponsor: Ningbo Newbay Technology Development Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a mobile app improve your sleep and help you lose weight?
Knowledge-focused CompletedThe goals of the proposed study are 1) to provide scientific basis for the relationship between subjective sleep quality, diurnal eating pattern, gut microbiome, and obesity, 2) to develop and test a pragmatic, cost-effective new tool to advance lifestyle changes using E-health a…
Phase: NA • Sponsor: Turku University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Exercise may boost brain health in seniors with high blood pressure
Knowledge-focused CompletedThe investigator aims to assess the extent to which a brief exercise intervention improves systemic growth factor concentrations, reverses loss of systemic vascular networks and hypertension, and by extension, improves neurocognition. To test the investigator's hypothesis that in…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Can slow breathing heal a broken heart? new study tests Device-Guided breathing
Symptom relief OngoingThis is a minimal risk case-controlled single arm intervention study, including 10 patients with a prior history of takotsubo and 10-age and sex matched healthy controls. Subjects will undergo in laboratory testing to measure autonomic function. They will then undergo a 15-week p…
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Experimental cancer drug KZR-261 tested in early trial
Disease control TerminatedA first-in-human, open-label, multicenter, Phase 1 study of KZR-261 designed to assess the safety and tolerability, preliminary anti-tumor activity, and pharmacokinetics (PK) of KZR-261, as well as identify the recommended Phase 2 dose (RP2D). The study comprised a Part 1 (Dose E…
Phase: PHASE1 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Sleep more, lower BP? new study tests sleep extension for nighttime hypertension
Knowledge-focused CompletedThe purpose of this study is to examine the impact that sleep duration has on blood pressure (BP) levels during sleep. The investigator will examine the effect of an 8-week sleep hygiene/extension intervention vs. control on sleep BP.
Phase: NA • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Liberia malaria study aims to guide future vaccine use
Knowledge-focused OngoingBackground: Malaria is a disease that affects many people in Liberia. It is caused by germs (parasites) that are spread by mosquito bites. Researchers want to gather data that may help them understand the best way to use a malaria vaccine in Liberia, which will be important in g…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New cancer drug IACS-6274 enters early human testing
Disease control Recruiting nowTo find the highest tolerable dose of IACS-6274 that can be given alone, in combination with bevacizumab and paclitaxel, or in combination with capivasertib to patients who have solid tumors. The safety and tolerability of the study drug(s) will also be studied.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Experimental HIV vaccine trimer 4571 tested in small safety trial
⭐️ VACCINE ⭐️ CompletedTrimer 4571 is a vaccine designed to stimulate the development of broadly neutralizing antibodies (bnAbs) against HIV. Trimer 4571 is investigational, meaning it is not approved by the US Food and Drug Administration (FDA). There is limited human experience with the Trimer 4571 v…
Phase: PHASE1 • Sponsor: Madhu Chhanda Choudhary • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 08:13 UTC
-
Simple exercise program may shield breast cancer patients from nerve damage
Symptom relief CompletedThe purpose of this study is to determine whether a multimodal program based on therapeutic exercise and vagal activation techniques for newly diagnosed breast cancer women has better results in terms of neurotoxicity prevenion before or during medical treatments.
Phase: NA • Sponsor: Universidad de Granada • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Cancer drug combo trial ends early – little known
Disease control TerminatedThe objective is to evaluate the efficacy and safety of Olinvacimab in combination with Pembrolizumab in patients with mTNBC.
Phase: PHASE2 • Sponsor: PharmAbcine • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Light therapy vs. steroids: which saves your taste buds?
Symptom relief CompletedOral lichen planus (OLP) is a long-term inflammatory disease affecting the lining of the mouth. It may cause pain, burning sensations, discomfort, and changes in the appearance of the oral mucosa. Some patients may also notice changes in their ability to recognize different taste…
Phase: NA • Sponsor: Medical University of Bialystok • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
New hope for kidney stone patients: safer pain relief after surgery?
Symptom relief OngoingStone disease is a common condition, affecting approximately 9% of Americans in 2007. It causes great morbidity and is also a costly condition, estimated to cost the US healthcare system approximately 3.79 billion dollars in 2007. Ureteroscopy (URS) is the most commonly performed…
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Talking it out: brief sessions may ease lung cancer Survivors' transition
Symptom relief OngoingThe aim of this study is to evaluate the efficacy of a brief psychoeducational intervention to improve quality of life in patients with lung cancer who are transitioning from active treatment to surveillance.
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Can VR and magnetic pulses ease dysphoria? small study tests two quick fixes
Symptom relief CompletedThis is an open label prospective pilot study of two neuromodulation interventions for patients suffering from dysphoria. Dysphoria is a transdiagnostic symptom of unease or dissatisfaction experienced across a range of diagnoses, including mood disorders and pain. There is a sig…
Phase: NA • Sponsor: Florida State University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Small study probes Carnitine's role in rare lung disease
Knowledge-focused CompletedIn preparation for a future mechanistic study, investigators now propose to test the specific hypothesis that carnitine consumption is not reduced in PAH, that plasma carnitine levels are stable over time in PAH and that carnitine supplementation in PAH can increase plasma carnit…
Phase: PHASE1 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
New drug Fx-5A takes first step toward fighting heart disease
Knowledge-focused Recruiting nowBackground: Heart disease is the leading cause of death, disability, and healthcare expense in the United States. Researchers think a new drug called Fx-5A may be useful to treat different cardiovascular diseases and inflammation. Objective: To understand the safety, tolerabil…
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC